2017
DOI: 10.1073/pnas.1703287114
|View full text |Cite
|
Sign up to set email alerts
|

Testing inhomogeneous solvation theory in structure-based ligand discovery

Abstract: Binding-site water is often displaced upon ligand recognition, but is commonly neglected in structure-based ligand discovery. Inhomogeneous solvation theory (IST) has become popular for treating this effect, but it has not been tested in controlled experiments at atomic resolution. To do so, we turned to a grid-based version of this method, GIST, readily implemented in molecular docking. Whereas the term only improves docking modestly in retrospective ligand enrichment, it could be added without disrupting per… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
77
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
2

Relationship

5
2

Authors

Journals

citations
Cited by 78 publications
(86 citation statements)
references
References 60 publications
3
77
0
Order By: Relevance
“…Structure–activity relationships are then explained by displacement of strongly or weakly bound solvent molecules, where displacement of weakly bound solvent is expected to increase binding affinities. This treatment of binding site desolvation can help to improve the accuracy of docking algorithms and lead to enhanced scoring functions …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Structure–activity relationships are then explained by displacement of strongly or weakly bound solvent molecules, where displacement of weakly bound solvent is expected to increase binding affinities. This treatment of binding site desolvation can help to improve the accuracy of docking algorithms and lead to enhanced scoring functions …”
Section: Introductionmentioning
confidence: 99%
“…This treatment of binding site desolvation can help to improvet he accuracy of docking algorithms and lead to enhanceds coring functions. [14][15][16] While this approach has the advantage that it typically only needs one simulation per target structure, it neglectst he contribution of water rearrangement upon ligand binding. This approach seems to be the methodo fc hoice for structure-based virtuals creening applicationsd ue to the lower number of simulations required, yet we expect that for lead optimization stages, water rearrangement should be accountedf or.G ilson and co-workersp roposed the application of grid inhomogeneous solvation theory to assess the change in solvation free energy upon chemical modification of the ligand.…”
Section: Introductionmentioning
confidence: 99%
“…Using the single target CNN model approach, we independently trained the protein-ligand and protein-ligand-water CNN models on 10 targets from the DUD-E dataset. Originally, we hypothesized that adding water information channels could improve virtual screening performance as shown in previous work by Balius et al, in which adding water energy terms to scoring functions improved the virtual screening performance of DOCK3.7 [5].…”
Section: Adding Water Information Does Not Improve the Performance Ofmentioning
confidence: 96%
“…Therefore, developing computational tools that can identify lead compounds with pharmacological activity against a selected protein target has been a long-standing goal for computational chemists. A number of structure-based docking tools that aim to predict ligand binding poses and binding affinities have been developed and have enjoyed moderate success over the last three decades [3][4][5][6][7][8][9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…GIST has been used to analyze the solvation of small molecules, DNA, host-guest, and protein-ligand systems and has also been incorporated into docking scoring functions. 14,16,[31][32][33][34][35][36][37] These studies have emphasized the impact of displacing high energy water molecules from the receptor surface upon ligand binding, which have been thought to indicate binding site "hot spots" in the context of drug design.…”
Section: Introductionmentioning
confidence: 99%